1.0Clinical Technologieshttps://www.almacgroup.com/clinical-technologieschloefinchhttps://www.almacgroup.com/clinical-technologies/blogs/author/chloefinch/Almac eConsentrich600338<blockquote class="wp-embedded-content" data-secret="eT8sUJqSYa"><a href="https://www.almacgroup.com/clinical-technologies/econsent/">Almac eConsent</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.almacgroup.com/clinical-technologies/econsent/embed/#?secret=eT8sUJqSYa" width="600" height="338" title="“Almac eConsent” — Clinical Technologies" data-secret="eT8sUJqSYa" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
Almac eConsent Streamlining participant consent for faster, compliant, and more engaging studies Almac’s eConsent solution is designed to streamline and enhance both electronic and paper-based consent processes. Built for global trials, it ensures regulatory compliance, improves participant understanding, and simplifies the workflow for researchers and participants alike. Whether used remotely or in person, eConsent supports […]https://www.almacgroup.com/clinical-technologies/wp-content/uploads/sites/8/2025/12/econsent_new.png